Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.

Bettiol A, Urban ML, Bello F, Fiori D, Mattioli I, Lopalco G, Iannone F, Egan A, Dagna L, Caminati M, Negrini S, Bargagli E, Folci M, Franceschini F, Padoan R, Flossmann O, Solans R, Schroeder J, André M, Moi L, Parronchi P, Roccatello D, Sciascia S, Jayne D, Prisco D, Vaglio A, Emmi G (2022)


Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 81

Pages Range: 1769-1772

Journal Issue: 12

DOI: 10.1136/ard-2022-222776

Involved external institutions

How to cite

APA:

Bettiol, A., Urban, M.L., Bello, F., Fiori, D., Mattioli, I., Lopalco, G.,... Emmi, G. (2022). Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. Annals of the Rheumatic Diseases, 81(12), 1769-1772. https://doi.org/10.1136/ard-2022-222776

MLA:

Bettiol, Alessandra, et al. "Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study." Annals of the Rheumatic Diseases 81.12 (2022): 1769-1772.

BibTeX: Download